MedTrace Logo

Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury

NCT05687097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-05-08

No results posted yet for this study

Summary

This cross-sectional prospective study will assess the potential association of more severe sleep apnea after spinal cord injury with more intense neuropathic pain, more severe spasticity, and more significant cardiovascular abnormalities including cardiac arrhythmias and blood pressure fluctuations. In addition, the participants' experience when undergoing home-based sleep screening test or hospital-unattended sleep screening test will be assessed in a semi-structured interview.

Conditions

  • Sleep Apnea
  • Spinal Cord Injuries
  • Spasticity, Muscle
  • Neuropathic Pain
  • Cardiovascular Complication

Interventions

DEVICE

Home-based sleep screening test or hospital-unattended sleep screening test

ApneaLink device will be used to assess the number of apnea and hypopnea events per hour of sleep.

DEVICE

Cardiovascular beat-to-beat monitoring

CareTaker device will be used to continuously record the participant's arterial blood pressure and heart rate during sleep.

DEVICE

ECG monitoring

Faror Bithium 180 device will be used to continuously record the participant's ECG during sleep.

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • Western University

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Julio Furlan, MD · KITE Research Institute, University Health Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05687097 on ClinicalTrials.gov